Rifampicin/isoniazid/pyrazinamide: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 46: | Line 46: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Rifampicin 3D 1i6v.png|Rifampicin/isoniazid/pyrazinamide | |||
</gallery> | |||
Revision as of 01:31, 20 February 2025
Rifampicin/Isoniazid/Pyrazinamide is a combination medication used in the treatment of tuberculosis. This medication combines three active ingredients: Rifampicin, Isoniazid, and Pyrazinamide.
Mechanism of Action
Each component of the Rifampicin/Isoniazid/Pyrazinamide medication works differently to inhibit the growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis.
- Rifampicin works by inhibiting the DNA-dependent RNA polymerase in bacterial cells, thus preventing the bacteria from synthesizing RNA and proteins.
- Isoniazid is a prodrug and must be activated by bacterial catalase. Once activated, it inhibits the synthesis of mycolic acid, a component of the bacterial cell wall.
- Pyrazinamide is also a prodrug that is converted to pyrazinoic acid in the body. This active metabolite disrupts membrane potential and interferes with energy production in the bacteria.
Side Effects
Like all medications, Rifampicin/Isoniazid/Pyrazinamide can cause side effects. Common side effects include:
- Nausea
- Vomiting
- Abdominal pain
- Skin rash
- Fever
- Jaundice
More serious side effects can include liver damage, peripheral neuropathy, and visual disturbances.
Precautions
Before starting treatment with Rifampicin/Isoniazid/Pyrazinamide, patients should inform their healthcare provider if they have a history of liver disease, alcoholism, or if they are pregnant or breastfeeding.
Interactions
Rifampicin/Isoniazid/Pyrazinamide can interact with other medications, including antiretroviral drugs, oral contraceptives, and certain anticoagulants.
Dosage
The dosage of Rifampicin/Isoniazid/Pyrazinamide will depend on the patient's weight, age, and overall health status. It is usually taken once daily for a period of two months, followed by four months of treatment with Rifampicin and Isoniazid alone.
